Cargando…
Safety and immunogenicity of two recombinant DNA COVID-19 vaccines containing the coding regions of the spike or spike and nucleocapsid proteins: an interim analysis of two open-label, non-randomised, phase 1 trials in healthy adults
BACKGROUND: We assessed the safety and immunogenicity of two recombinant DNA vaccines for COVID-19: GX-19 containing plasmid DNA encoding the SARS-CoV-2 spike protein, and GX-19N containing plasmid DNA encoding the SARS-CoV-2 receptor-binding domain (RBD) foldon, nucleocapsid protein, and plasmid DN...
Autores principales: | Ahn, Jin Young, Lee, Jeongsoo, Suh, You Suk, Song, Young Goo, Choi, Yoon-Jeong, Lee, Kyoung Hwa, Seo, Sang Hwan, Song, Manki, Oh, Jong-Won, Kim, Minwoo, Seo, Han Young, Kwak, Jeong-Eun, Youn, Jin Won, Woo, Jung Won, Shin, Eui-Cheol, Sung, Young Chul, Park, Su-Hyung, Choi, Jun Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8824525/ https://www.ncbi.nlm.nih.gov/pubmed/35156068 http://dx.doi.org/10.1016/S2666-5247(21)00358-X |
Ejemplares similares
-
Nucleocapsid and Spike Proteins of SARS-CoV-2 Drive Neutrophil Extracellular Trap Formation
por: Youn, Young-Jin, et al.
Publicado: (2021) -
Characterization of novel monoclonal antibodies against MERS-coronavirus spike protein
por: Goo, Junghyun, et al.
Publicado: (2020) -
Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein
por: Choi, Jung-ah, et al.
Publicado: (2020) -
Immunogenicity and protective efficacy of recombinant S1 domain of the porcine epidemic diarrhea virus spike protein
por: Oh, Jongsuk, et al.
Publicado: (2014) -
Soluble Spike DNA Vaccine Provides Long-Term Protective Immunity against SARS-CoV-2 in Mice and Nonhuman Primates
por: Seo, Yong Bok, et al.
Publicado: (2021)